Stryker Corp. engages in providing medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics segment provides reconstructive and trauma implant systems. The Medsurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling, and reprocessed medical devices. The Neurotechnology and Spine segment pertains to spinal implants and neurovascular products. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.
Highlights
SYK's quick ratio has soared by 85% YoY and by 24% from the previous quarter
SYK's equity is up by 7% year-on-year but it is down by 2.8% since the previous quarter
SYK's net income has dropped by 55% year-on-year and by 26% since the previous quarter
Stryker's EPS has plunged by 55% YoY and by 26% from the previous quarter
Key stats
What are the main financial stats of SYK
Market
Shares outstanding
375.61M
Market cap
$71.73B
Enterprise value
$78.11B
Valuations
Price to earnings (P/E)
44.62
Price to book (P/B)
5.62
Price to sales (P/S)
5.1
EV/EBIT
38.67
EV/EBITDA
33.32
EV/Sales
5.55
Earnings
Revenue
$14.07B
EBIT
$2.02B
EBITDA
$2.34B
Free cash flow
$1.96B
Per share
EPS
$4.28
Free cash flow per share
$5.22
Book value per share
$33.98
Revenue per share
$37.47
TBVPS
$48.99
Balance sheet
Total assets
$31.48B
Total liabilities
$18.73B
Debt
$12.92B
Equity
$12.75B
Working capital
$8.4B
Liquidity
Debt to equity
1.01
Current ratio
2.91
Quick ratio
2
Net debt/EBITDA
2.72
Margins
EBITDA margin
16.7%
Gross margin
63.3%
Net margin
11.4%
Operating margin
15.5%
Efficiency
Return on assets
5.4%
Return on equity
12.6%
Return on invested capital
10.8%
Return on capital employed
7.5%
Return on sales
14.4%
Dividend
Dividend yield
1.18%
DPS
$2.25
Payout ratio
52.5%
SYK stock price
How has the Stryker stock price performed over time
Financial performance
How have Stryker's revenue and profit performed over time
Revenue
$14.07B
Gross profit
$8.91B
Operating income
$2.19B
Net income
$1.6B
Gross margin
63.3%
Net margin
11.4%
SYK's net income has dropped by 55% year-on-year and by 26% since the previous quarter
SYK's net margin has plunged by 54% YoY and by 21% from the previous quarter
The operating income has declined by 22% since the previous quarter and by 9% year-on-year
Stryker's operating margin has decreased by 18% QoQ and by 9% YoY
Valuation
What is Stryker stock price valuation
P/E
44.62
P/B
5.62
P/S
5.1
EV/EBIT
38.67
EV/EBITDA
33.32
EV/Sales
5.55
Stryker's EPS has plunged by 55% YoY and by 26% from the previous quarter
SYK's P/E is 35% above its last 4 quarters average of 33.0 and 33% above its 5-year quarterly average of 33.5
SYK's equity is up by 7% year-on-year but it is down by 2.8% since the previous quarter
SYK's P/B is 4.1% above its 5-year quarterly average of 5.4
The stock's price to sales (P/S) is 13% more than its 5-year quarterly average of 4.5 and 2% more than its last 4 quarters average of 5.0
The company's revenue fell by 6% QoQ
Efficiency
How efficient is Stryker business performance
The ROA has plunged by 61% YoY and by 30% from the previous quarter
The ROE has shrunk by 60% YoY and by 27% QoQ
Stryker's ROIC has decreased by 29% from the previous quarter and by 27% YoY
Stryker's ROS has decreased by 20% from the previous quarter and by 8% YoY
Dividends
What is SYK's dividend history
DPS
$2.25
Dividend yield
1.18%
Payout ratio
52.5%
Recent dividends
Financial health
How did Stryker financials performed over time
The total assets is 68% greater than the total liabilities
SYK's quick ratio has soared by 85% YoY and by 24% from the previous quarter
The current ratio has grown by 41% year-on-year and by 13% since the previous quarter
SYK's debt has soared by 52% YoY and by 23% from the previous quarter
The debt to equity has grown by 42% YoY and by 26% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated
quarterly, unless otherwise specified.